(2016). Respiratory effect of beta-blocker eye drops in asthma: population-based study and meta-analysis of clinical trials. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13006
. D. Morales
First name
D.
Middle name
R.
Last name
Morales
(2017). Validation of asthma recording in the Clinical Practice Research Datalink (CPRD). BMJ Open. http://doi.org/10.1136/bmjopen-2017-017474
. (2017). Respiratory effect of beta-blockers in people with asthma and cardiovascular disease: population-based nested case control study. BMC Med. http://doi.org/10.1186/s12916-017-0781-0
. (2018). External validation of ADO, DOSE, COTE and CODEX at predicting death in primary care patients with COPD using standard and machine learning approaches. Respir Med. http://doi.org/10.1016/j.rmed.2018.04.003
. (2018). Concomitant diagnosis of asthma and COPD: a quantitative study in UK primary care. Br J Gen Pract. http://doi.org/10.3399/bjgp18X699389
. (2020). Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol. http://doi.org/10.1016/s2665-9913(20)30276-9
. (2020). Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keaa771
. (2021). Intolerance to Angiotensin Converting Enzyme Inhibitors in Asthma and the General Population: A UK Population-Based Cohort Study. J Allergy Clin Immunol Pract. http://doi.org/10.1016/j.jaip.2021.04.055
. (2021). Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study. Lancet Healthy Longev. http://doi.org/10.1016/s2666-7568(21)00088-x
.